NetworkNewsBreaks

ThursdayNov 10, 2022 4:04 pm

NetworkNewsBreaks – GeoSolar Technologies Inc.’s SmartGreen(TM) Home Approach Spotlighted in News

GeoSolar Technologies, a Colorado startup comprised of some of the world’s brightest minds, has created a unique approach called the SmartGreen Home. That approach was spotlighted in a recent “West Wales Chronicle” article, titled “Why All-Electric (and Net-Zero Homes) Are the Future That’s Already Happening.” The article noted that many people are looking for ways to support a greener, more sustainable future, but beyond obvious things such as driving an electric vehicle, many people don’t know exactly what they should be doing. “The future is all-electric and net-zero emissions homes,” the article states. “Making them a reality is closer than…

Continue Reading

ThursdayNov 10, 2022 3:48 pm

NetworkNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Bollinger Motors Selects Our Next Energy as Battery Supplier for Electric Commercial Trucks

Mullen Automotive’s (NASDAQ: MULN) majority owned company, Bollinger Motors, today announced that Our Next Energy will be supplying modular, linkable Aries battery packs to power its all-electric commercial platforms and chassis cabs. Bollinger’s all-electric Class 4 through Class 6 chassis cabs are designed to meet the needs of commercial customers in a segment that often requires large payloads, sufficient range, durability, and longevity. “ONE battery packs are ideal for our commercial trucks, giving our customers the range they need,” said Robert Bollinger, founder and CEO of Bollinger Motors. “The fact they’ll be built in the U.S. and in Michigan is…

Continue Reading

ThursdayNov 10, 2022 2:49 pm

NetworkNewsBreaks – Coyuchi Inc. Products Featured in Forbes Article

Coyuchi, the gold standard in sustainable luxury home goods, was featured in a recent Forbes article titled “The Best Bath Towels to Upgrade Your Bathing Experience.” The piece, written by Camryn Rabideau, describes the luxury of wrapping oneself up in an ultra-plush towel after a long, hot shower, providing several top-notch options for doing so. Coyuchi made the list in two categories, including its cloud loom product considered the best organic bath towel and its Mediterranean product touted the best Turkish bath towel. “The art of Turkish towel making is perfected with Coyuchi’s Mediterranean Organic Towels. Not only are they…

Continue Reading

ThursdayNov 10, 2022 2:44 pm

NetworkNewsBreaks — BIT Mining Ltd. (NYSE: BTCM) Announces Plans to Release Q3 2022 Unaudited Financial Report

BIT Mining (NYSE: BTCM), a leading technology-driven cryptocurrency mining company, anticipates releasing its unaudited financial results for the third quarter before the U.S. market opens on Nov. 17, 2022. The results will cover the period ended Sept. 30, 2022. BIT Mining owns the world's top blockchain browser — BTC.com — and the comprehensive mining pool business operated under BTC.com as well as a 7-nanometer cryptocurrency mining machine manufacturer, Bee Computing. To view the full press release, visit https://nnw.fm/SrAky About BIT Mining Ltd BIT Mining is a leading technology-driven cryptocurrency mining company, with a long-term strategy to create value across the cryptocurrency industry.…

Continue Reading

ThursdayNov 10, 2022 2:39 pm

NetworkNewsBreaks — Stronghold Digital Mining Inc. (NASDAQ: SDIG) Releases Q3 2022 Report, 2023 Guidance

Stronghold Digital Mining(NASDAQ: SDIG) has released financial results for its third quarter, the period ended Sept. 30, 2022; the report also included an operational update. Highlights of the report included current liquidity for the company reaching an estimated $27 million, which includes $27 million cash plus 19 Bitcoin; other numbers worth noting include current principal amount of outstanding debt totaling approximately $82 million, with net debt of approximately $55 million, which represents an approximately 51% reduction since the end of June 2022. In addition, the company noted fully extinguished $67.4 million in principal value of debt associated with NYDIG ABL…

Continue Reading

ThursdayNov 10, 2022 2:27 pm

NetworkNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Allow Farmers to Spice It Up

Advanced Container Technologies (OTC: ACTX) offers unique controlled environment farms, GrowPods, which can allow growers to start cultivating in-demand, high-margin specialty herbs and spices. The U.S. market for fresh culinary herbs is growing. According to the U.S. Agency for International Development, popularity of leafy plants such as basil, cilantro and parsley that add flavor, aroma or garnish, increased 10% to 12% annually from 2004 to 2014 and has continued to climb. However, domestic field production does not meet demand, resulting in importation of nearly $300 million worth of leafy plants each year. In addition, domestically produced and imported goods face…

Continue Reading

ThursdayNov 10, 2022 2:15 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First-Ever Study Exploring Therapeutic Use of DehydraTECH-CBD in Dementia

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is starting a new study program — DEM-A22-1 — on Nov. 15, 2022. The study, a first for Lexaria, will evaluate whether LEXX’s DehydraTECH-processed cannabidiol (“CBD”) may have potential for therapeutic treatment for dementia. According to the announcement, Lexaria has previously shown the efficacy of DehydraTECH-CBD in studies focused on human hypertension; the studies showed no serious side effects. Lexaria is exploring the potential for dementia based on previous clinical studies that have established connections between hypertension and dementia: specifically, that individuals who have high blood pressure are more likely…

Continue Reading

ThursdayNov 10, 2022 2:01 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Announces Dismissal of Claim by Former CEO

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has announced the Nov. 9, 2022, dismissal of the claim for USD $30.2 million brought by the company’s former CEO, Dr. Raza Bokhari. Dr. Bokhari had claimed that he had been wrongfully dismissed. The arbitrator hearing the claim dismissed it in its entirety and ordered Dr. Bokhari to repay certain monies to FSD Pharma, while also holding Dr. Bokhari responsible for FSD Pharma’s costs of the arbitration. “The outcome of the arbitration…

Continue Reading

ThursdayNov 10, 2022 1:55 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Reports Majority of Franchise Global Health (TSX.V: FGH) Shareholders Approve Acquisition

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is one step closer to completing its previously announced acquisition of Franchise Global Health (TSX.V: FGH). FLGC announced that holders of more than 73% of the outstanding shares of FGH have agreed to vote their shares in favor of Flora’s acquisition of FGH; the voting will take place during FGH’s special meeting of shareholders, scheduled for Dec. 13, 2022. The completion of the acquisition remains subject to customary closing conditions, including approval of the plan of arrangement by the Supreme Court of British Columbia…

Continue Reading

ThursdayNov 10, 2022 1:29 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Progress on Clinical Path for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced progress on its CYB004-E Phase 1 trial evaluating N,N-dimethyltryptamine (“DMT”). According to the update, dosing has been completed for four out of five participant cohorts, and The Safety Review Committee has confirmed no clinically significant safety or tolerability issues. The trial was acquired from Entheon Biomedical Corp. in July 2022. “The acquisition of the Phase 1 DMT study was done with an eye toward informing and accelerating the clinical path forward for CYB004, and we are very pleased with the progress so far,”…

Continue Reading